As of April 07, 2026, ProMIS Neurosciences, Inc. had a $97.6 million market capitalization, putting it in the 22nd percentile of companies in the Biotechnology industry. ProMIS Neurosciences, Inc.
A new pattern of deceptive activity by some vessels around the critical waterway suggests the new American blockade is ...
Prediction markets allow consumers to trade event contracts tied to real-world outcomes, from elections to economic data and ...
Cambridge, Massachusetts--(Newsfile Corp. - April 13, 2026) - ProMIS Neurosciences, Inc. (NASDAQ: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's ...
A joint status report filed yesterday in Apple's trade secrets lawsuit against YouTuber Jon Prosser and Michael Ramacciotti ...
In a joint status report, attorneys for Apple and Michael Ramacciotti updated the court on the latest developments in the ...
Google has launched Skills in Chrome, a new feature that lets you save Gemini prompts as reusable one-click tools and run them across multiple tabs without retyping anythingThe Latest Tech News, Deliv ...
"We are extremely pleased with the significant progress our team achieved in 2025 and the strong momentum we have carried into 2026," said Neil Warma, Chief Executive Officer of ProMIS Neurosciences. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results